Top management changes at IOL Chemicals and Pharmaceuticals
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
He is a Chartered Accountant with more than 19 years of extensive experience
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
Subscribe To Our Newsletter & Stay Updated